A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

Clinical trial NCT07771803 · RECRUITING

Trial details

NCT number: NCT07771803
Sponsor: Roger Strair
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

AML (Acute Myeloid Leukemia)Multiple Myeloma Refractory

Start date: 2025-06-30
Primary completion: 2026-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.